Skip to main content
. 2015 Mar 10;9(3):e0003594. doi: 10.1371/journal.pntd.0003594

Table 2. Differences among leishmaniasis and co-infected leishmaniasis-HIV cases based hospitalizations, with leishmaniasis as first diagnosis. Spain 1997–2011.

Variables Leishmania as first diagnosis (n = 3442)
VIH positive VIH negative Unadjusted OR Adjusted OR
N % N %
No. of subjects 1255 36.46 2187 63,54
Sex Female 171 13.6 726 33.2 1 1
Male 1084 86.4 1461 66.8 2.22 (1.93–2.56)** 1.50 (1.17–1.91) *
Age group 0–15 0 0.0 820 37.5 1 1
16–64 1248 99.4 992 45.4 1032 (144.9–7344) ** 990 (138.76–7065.63) **
>65 7 0.6 375 17.1 0.07 (0.01–0.53) ** 0.02 (0.01–0.03) **
Leishmaniasis Cutaneous 13 1.0 105 4.8 1 1
Visceral 1107 88.2 1737 79.4 5.15 (2.88–9.20) ** 6.07 (3.27–11.28) **
Non-defined 135 10.8 345 15.8 0.32 (0.18–0.60) ** 0.06 (0.06–0.77) **
Type of discharge No Exitus 1252 94.3 2042 96.5 1 1
Exitus 48 3.6 59 2.8 1.33 (0.90–1.96)
Unknown 27 2.0 14 0.7 3.14 (1.64–6.02) ** 4.18 (1.50–11.66) *
Re-hospitalization No 887 70.7 1732 79.2 1 1
Yes 368 29.3 455 20.8 1.56 (1.35–1.85) ** 1.69 (1.35–2.12) **
Surgery No 1185 94.4 1994 91.2 1 1
Yes 70 5.6 193 8.8 0.61 (0.46–0.81) ** 1.75 (1.24–2.47) **
Days of stay ≤15 days 852 67.9 1486 67.9 1
> 16 days 403 32.1 701 32.1 1 (0.86–1.16)
Solid neoplasm No 1230 98.0 2165 99.0 1 1
Yes 25 2.0 22 1.0 2 (1.12–3.56)* 4.45 (1.65–12.04) *
Lymph- hematopoietic neoplasms No 1246 99.3 2132 97.5 1 1
Yes 9 0.7 55 2.5 0.28 (0.14–0.57) ** 0.25 (0.11–0.57) *
Other immunodeficiencies No 1255 99.9 2149 98.3 1 1
Yes 1 1.0 37 1.7 0.05 (0.01–0.34) ** 0.04 (0.01–0.32) *
Transplant No 1255 100.0 2098 95.9 1 1
Yes 0 0.0 89 4.1 0.01 (0.01–0.14) ** 0.01 (0.00–0.07) **
Transplant failure No 1245 99.2 2160 98.8 1
Yes 10 0.8 27 1.2 0.64 (0.31–1.33)
Aplastic Anemia No 1078 85.9 1856 84.9 1
Yes 177 14.1 331 15.1 0.92 (0.76–1.12)
Diabetes Mellitus No 1244 99 2009 91.9 1 1
Yes 12 1 177 8.1 0.11 (0.06–0.20) ** 0.10 (0.05–0.18) **
Hepatitis No 1112 88.6 2153 98.4 1 1
Yes 143 11.4 34 1.6 8.14 (5.56–11.92) ** 3.95 (2.52–6.20) **
Long term use of steroids No 1255 100.0 2171 99.3 1 1
Yes 0 0.0 16 0.7 0.11 (0.01–0.81) * 0.69 (0.05–9.65)
Long-term drug use No 1219 97.1 2168 99.1 1 1
Yes 36 2.9 19 0.9 3.37 (1.92–5.19) ** 2.97 (1.40–6.33) *
Alcoholism No 1183 94.3 2143 98.0 1 1
Yes 72 5.7 44 2.0 2.96 (2.02–4.34) ** 1.76 (1.12–2.78) *
Institutionalized No 1147 91.4 2169 99.2 1 1
Yes 108 8.6 18 0.8 11.35 (6.85–18.78) ** 3.96 (2.27–6.91) **
Lack of resources No 1245 99.2 2183 99.8 1 1
Yes 10 0.8 4 0.2 4.38 (1.37–14.03) * 4.53 (0.84–24.46)

* p<0.05;

** p<0.001.